Meiji Pharma Spain, S.A.

Certificate 2024 CR 0026

Rev. 2Issued

Overview

No specific devices are listed for this certificate.

No status changes or preceding certificates are recorded.

Class III4

4 scopes

MDN 1102: Implantes óseos ortopédicos no activos / Non-active osteo-and orthopaedic implants
Class III
Solución de hialuronato sódico 1% (10mg/ml) 2,5ml jeringa intraarticular / Sodium hyaluronate 1% (10 mg/ml) 2.5ml solution. Intra articular syringe
Class III
Solución de hialuronato sódico 1% (10mg/ml) 4,9ml jeringa intraarticular / Sodium hyaluronate 1% (10 mg/ml) 4.9ml solution. Intra articular syringe
Class III
Solución de hialuronato sódico 2% (20mg/ml) 4,9ml jeringa intraarticular / Sodium hyaluronate 2% (20 mg/ml) 4.9 ml solution. Intra articular syringe
Class III

LanguagesENES

Meiji Pharma Spain, S.A.

Rev. 2Issued

No specific devices are listed for this certificate.

No status changes or preceding certificates are recorded.

Class III4

4 scopes

MDN 1102: Implantes óseos ortopédicos no activos / Non-active osteo-and orthopaedic implants
Class III
Solución de hialuronato sódico 1% (10mg/ml) 2,5ml jeringa intraarticular / Sodium hyaluronate 1% (10 mg/ml) 2.5ml solution. Intra articular syringe
Class III
Solución de hialuronato sódico 1% (10mg/ml) 4,9ml jeringa intraarticular / Sodium hyaluronate 1% (10 mg/ml) 4.9ml solution. Intra articular syringe
Class III
Solución de hialuronato sódico 2% (20mg/ml) 4,9ml jeringa intraarticular / Sodium hyaluronate 2% (20 mg/ml) 4.9 ml solution. Intra articular syringe
Class III

LanguagesENES